Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Saborowski

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 3, 2021
Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal MelanomaCornelia Lieselotte Angelika Dewald, Jan B Hinrichs, Lena Sophie Becker, et al.
Annals of Surgical Oncology|October 28, 2025
Two-Stage Hepatectomy for Cholangiocarcinoma Under Total Vascular Exclusion with Veno-venous ECMO Bypass and Controlled Closed-loop In Situ Hypothermic Oxygenated Perfusion of the Liver: The Hannover CLIP-ConceptCornelius J van Beekum, Philipp Felgendreff, Simon Störzer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinomaSilvestre Vicent, Ruby Lieshout, Anna Saborowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteinsMonika A Davare, Anna Saborowski, Christopher A Eide, et al.
United European Gastroenterology Journal|December 12, 2025
Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction-Associated Steatohepatitis PatientsEmilse Rodriguez, Peter Simon, Sabrina Dhooge, et al.
Cancer Cell|April 22, 2014
Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumorsPiro Lito, Anna Saborowski, Jingyin Yue, et al.
Hepatology (Baltimore, Md.)|March 12, 2021
The Co-mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion-Driven CholangiocarcinomaGajanan Kendre, Silke Marhenke, Georgina Lorz, et al.
Journal of Hepatology|March 27, 2025
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trialsChanghoon Yoo, Anna Saborowski, Jaewon Hyung, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 23, 2021
p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury ModelLaura Elisa Buitrago-Molina, Silke Marhenke, Diana Becker, et al.
Carcinogenesis|June 7, 2019
Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editingAmrendra Mishra, Fatemeh Emamgholi, Zulrahman Erlangga, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 3, 2021
Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal MelanomaCornelia Lieselotte Angelika Dewald, Jan B Hinrichs, Lena Sophie Becker, et al.
Annals of Surgical Oncology|October 28, 2025
Two-Stage Hepatectomy for Cholangiocarcinoma Under Total Vascular Exclusion with Veno-venous ECMO Bypass and Controlled Closed-loop In Situ Hypothermic Oxygenated Perfusion of the Liver: The Hannover CLIP-ConceptCornelius J van Beekum, Philipp Felgendreff, Simon Störzer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinomaSilvestre Vicent, Ruby Lieshout, Anna Saborowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteinsMonika A Davare, Anna Saborowski, Christopher A Eide, et al.
United European Gastroenterology Journal|December 12, 2025
Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction-Associated Steatohepatitis PatientsEmilse Rodriguez, Peter Simon, Sabrina Dhooge, et al.
Cancer Cell|April 22, 2014
Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumorsPiro Lito, Anna Saborowski, Jingyin Yue, et al.
Hepatology (Baltimore, Md.)|March 12, 2021
The Co-mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion-Driven CholangiocarcinomaGajanan Kendre, Silke Marhenke, Georgina Lorz, et al.
Journal of Hepatology|March 27, 2025
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trialsChanghoon Yoo, Anna Saborowski, Jaewon Hyung, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 23, 2021
p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury ModelLaura Elisa Buitrago-Molina, Silke Marhenke, Diana Becker, et al.
Carcinogenesis|June 7, 2019
Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editingAmrendra Mishra, Fatemeh Emamgholi, Zulrahman Erlangga, et al.
Pageof 8